MarginsXMarginsX
Home › Markets › Health Care › XRAY

DENTSPLY SIRONA Inc. (XRAY)

XRAY trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$8.95
-2.35% on the day
Market cap
$1.8B
Small cap
Revenue · 2025
$3.7B
-3.0% on 2024
Net income · 2025
-$598.0M
-16.3% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/818479/000081847926000075/0000818479-26-000075-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerXRAY on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year1987
SEC CIK0000818479
SEC industry codeDental Equipment & Supplies
Incorporated inDE

Financials · 2025

LineValue
Revenue$3.7B
Net income-$598.0M
Operating income-$422.0M
Net margin-16.3%
Operating margin-11.5%
Revenue growth-3.0%
Cash$326.0M
Total assets$5.4B
P/E (computed)Net income was not positive
P/S (computed)0.5×

Warning signs

Cash runway
Cash-flow positive
$195.0M cash at September 30, 2026
Share count, 1 year
-0.7%
2025-10-17 to 2026-10-23 · -6.5% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
$826K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$195.0M cash; operating cash flow $68.0M a quarter.Report 2026-09-30
Shares outstanding198,153,678 (2026-10-23); 199,551,969 a year earlier; 211,860,391 three years earlier.Cover page 2026-10-23
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, Charlotte, North Carolina, United StatesPCAOB Form AP 2026-03-16
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $1.7M, sold $916K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$836.0M-$2.0M$32.0M$195.0M$2.2B$3.6B10-Q 2026-11-05
Q2 2026
2026-06-30
$898.0M$37.0M$99.0M$239.0M$2.2B$3.6B10-Q 2026-08-06
Q1 2026
2026-03-31
$880.0M-$10.0M$40.0M$190.0M$2.2B$3.7B10-Q 2026-05-05
Q4 2025
2025-12-31
$961.0M-$146.0M$101.0M$326.0M$2.3B$3.7B10-K 2026-02-26
Q3 2025
2025-09-30
$904.0M-$427.0M$79.0M$363.0M$2.4B$3.6B10-Q 2026-11-05
Q2 2025
2025-06-30
$936.0M-$45.0M$48.0M$359.0M$2.4B$3.7B10-Q 2026-08-06
Q1 2025
2025-03-31
$879.0M$20.0M$7.0M$398.0M$2.3B$3.7B10-Q 2026-05-05
Q4 2024
2024-12-31
$905.0M-$430.0M$87.0M$272.0M$1.7B$3.8B10-K 2026-02-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B22025-06-09
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxyDEFA14A2026-04-23

Source: SEC EDGAR submissions feed, 1,004 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-3.2%
1 month+7.6%
3 months-20.9%
Year to date-19.9%
1 year-16.3%
From 52-week high-37.6%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
LMATLeMaitre Vascular Inc.$77.01-1.63%$1.8B
INSPInspire Medical Systems Inc.$59.12-3.24%$1.7B
KMTSKestra Medical Technologies Ltd.$27.97-2.34%$1.7B
UFPTUFP Technologies Inc.$298.54-2.14%$2.3B
PRCTPROCEPT BioRobotics Corporation$23.54-1.09%$1.4B
NVCRNovoCure Limited$11.30-4.48%$1.3B
TNDMTandem Diabetes Care Inc.$18.48-7.92%$1.3B
ATRCAtriCure Inc.$55.31-2.69%$2.8B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier